Recursion Pharmaceuticals (RXRX) Bank of America SMID Cap Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Bank of America SMID Cap Virtual Conference summary
23 Aug, 2026Conference overview
The event featured presentations from nearly 20 small and mid-cap companies, with a focus on innovation and growth strategies across sectors.
Analysts highlighted the breadth of coverage, with BofA tracking about 1,000 small and mid-cap U.S. companies.
Upstart Holdings' session included a deep dive into its AI-driven consumer lending platform and business model.
Strategic direction and leadership
Upstart's new CEO, Paul Gu, emphasized a shift to the 'second leg' of growth, focusing on profitability and capital efficiency.
The company streamlined priorities to drive contribution profit, especially in core personal loans, and demonstrated record profits in Q2 2026.
Leadership is balancing investment between core products and new segments, mindful of capital allocation and market expectations.
Business model and growth drivers
Upstart leverages proprietary AI models and data to improve risk assessment and automate lending, targeting underserved consumers.
The addressable market is vast, with significant room for technology-driven disruption in consumer lending.
The company is expanding beyond personal loans into auto, home, and new products like cash line, aiming for long-term compounding growth.
Latest events from Recursion Pharmaceuticals
- AI-driven drug discovery platform delivers first-in-class assets and major partnership milestones.RXRX
Morgan Stanley 24th Annual Global Healthcare Conference - AI-driven drug discovery advances with $556.8M cash and major clinical milestones ahead.RXRX
Q2 2026 - Proprietary AI-driven platform and strategic partnerships drive clinical progress and upcoming catalysts.RXRX
Citi's Biopharma Back to School Conference - All proposals passed, including board elections and auditor ratification, with no stockholder questions.RXRX
AGM 2026 - Recursion and Exscientia to merge in a stock-for-stock deal, forming a leading tech-enabled drug discovery company.RXRX
Proxy Filing - AI-driven platform advances multiple clinical programs with major data readouts expected soon.RXRX
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - AI-driven pipeline and partnerships drive clinical progress and capital efficiency.RXRX
Bank of America Global Healthcare Conference 2026 - Leadership transition, robust partnerships, and key clinical milestones drive future growth.RXRX
Guggenheim Securities 2nd Annual Healthcare Innovation Conference - AI-powered platform advances oncology pipeline with strong validation and disciplined growth.RXRX
Goldman Sachs 46th Annual Global Healthcare Conference 2025